Literature DB >> 17784979

The role of the bladder surface in interstitial cystitis/painful bladder syndrome.

Joel M H Teichman1, Robert Moldwin.   

Abstract

INTRODUCTION: Interstitial cystitis (IC) is a potentially severe and debilitating condition of the bladder. Numerous factors have been implicated in its pathogenesis.
MATERIALS AND METHODS: A literature review was conducted on the following topics: urothelium, mucosal lining, interstitial cystitis, bladder, and glycosaminoglycans.
RESULTS: A commonly proposed cause for IC is a defect or alteration in the bladder surface leading to increased permeability to noxious urinary solutes and ultimately to tissue inflammation and neurogenic upregulation. Support for this concept is drawn from studies of the structure, function, and composition of the bladder surface. The cause(s) of this alteration is not known, although recent research has implicated changes in the levels of growth factors and/or compounds that protect against irritants and potentially "toxic" factors. The etiology of IC is likely multifactorial.
CONCLUSIONS: Alterations of the bladder surface are observed in IC, and may play an important role in the etiology of this condition.

Entities:  

Mesh:

Year:  2007        PMID: 17784979

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  12 in total

Review 1.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

2.  Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.

Authors:  Rheal A Towner; Nataliya Smith; Debra Saunders; Samuel B Van Gordon; Amy B Wisniewski; Karl R Tyler; Beverley Greenwood-Van Meerveld; Robert E Hurst
Journal:  J Urol       Date:  2014-11-14       Impact factor: 7.450

3.  Advances in diagnosis and treatment of interstitial cystitis/painful bladder syndrome.

Authors:  Avinash Chennamsetty; Michael J Ehlert; Kenneth M Peters; Kim A Killinger
Journal:  Curr Infect Dis Rep       Date:  2015-01       Impact factor: 3.725

Review 4.  Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.

Authors:  Jason Sea; Joel M H Teichman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 5.  What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?

Authors:  Abhishek Seth; Joel M H Teichman
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

6.  Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells.

Authors:  J Nirmal; A S Wolf-Johnston; M B Chancellor; P Tyagi; M Anthony; J Kaufman; L A Birder
Journal:  Int Urol Nephrol       Date:  2014-05-30       Impact factor: 2.370

7.  Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.

Authors:  Yi-Song Lv; Hui-Liang Zhou; Hou-Ping Mao; Rui Gao; Yan-Dong Wang; Xue-Yi Xue
Journal:  Int Urogynecol J       Date:  2012-05-11       Impact factor: 2.894

8.  Personal cell therapy for interstitial cystitis with autologous stromal vascular fraction stem cells.

Authors:  Elliot B Lander; Mark H Berman; Jackie R See
Journal:  Ther Adv Urol       Date:  2019-08-17

Review 9.  From bladder to systemic syndrome: concept and treatment evolution of interstitial cystitis.

Authors:  Sara Dinis; Joana Tavares de Oliveira; Rui Pinto; Francisco Cruz; Ca Tony Buffington; Paulo Dinis
Journal:  Int J Womens Health       Date:  2015-07-23

10.  Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms.

Authors:  Hui Shan; Er-Wei Zhang; Peng Zhang; Xiao-Dong Zhang; Ning Zhang; Peng Du; Yong Yang
Journal:  BMC Urol       Date:  2019-11-12       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.